H1 2025 profit after tax A$15m, up from A$8m in H1 2024
Released
Latest announcements
Ask a question
Your question will be sent privately to Neuren Pharmaceuticals Limited. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Neuren Pharmaceuticals Limited a question about this announcement.